🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
81 results for “Boehringer”
MedicineActive substanceLicence holderStatus
Actilyse 10 mg powder and solvent for solution for injection and infusion
PA0775/011/001
Alteplase Boehringer Ingelheim International GmbH Marketed
Actilyse 20 mg powder and solvent for solution for injection and infusion
PA0775/011/002
Alteplase Boehringer Ingelheim International GmbH Marketed
Actilyse 50 mg powder and solvent for solution for injection and infusion
PA0775/011/003
Alteplase Boehringer Ingelheim International GmbH Marketed
Actilyse Cathflo 2 mg powder for solution for injection and infusion
PA0775/011/004
Alteplase Boehringer Ingelheim International GmbH Marketed
Aptivus
EU/1/05/315/002
Tipranavir Boehringer Ingelheim International GmbH
Aptivus 250 mg soft capsules
EU/1/05/315/001
Tipranavir Boehringer Ingelheim International GmbH
Atrovent 250 UDVs 250 micrograms/ 1ml Nebuliser Solution
PA0775/012/002
Ipratropium bromide Boehringer Ingelheim International GmbH Marketed
Atrovent 500 UDVs, 500 micrograms/ 2ml Nebuliser Solution
PA0775/012/003
Ipratropium bromide Boehringer Ingelheim International GmbH Marketed
Atrovent Inhaler CFC-Free 20 micrograms per metered dose pressurised inhalation solution
PA0775/012/001
Ipratropium bromide Boehringer Ingelheim International GmbH Not marketed
GIOTRIF 20 mg film-coated tablets
EU/1/13/879/001-003
Afatinib-dimaleate Boehringer Ingelheim International GmbH
GIOTRIF 30 mg film-coated tablets
EU/1/13/879/004-006
Afatinib-dimaleate Boehringer Ingelheim International GmbH
GIOTRIF 40 mg film-coated tablets
EU/1/13/879/007-009
Afatinib-dimaleate Boehringer Ingelheim International GmbH
GIOTRIF 50 mg film-coated tablets
EU/1/13/879/010-012
Afatinib-dimaleate Boehringer Ingelheim International GmbH
Glyxambi 10 mg/5 mg film-coated tablets
EU/1/16/1146/001-009
Empagliflozin, Linagliptin Boehringer Ingelheim International GmbH
Glyxambi 25 mg/5 mg film-coated tablets
EU/1/16/1146/010-018
Empagliflozin, Linagliptin Boehringer Ingelheim International GmbH
Jardiance 10 mg film-coated tablets
EU/1/14/930/010-018
Empagliflozin Boehringer Ingelheim International GmbH
Jardiance 25 mg film-coated tablets
EU/1/14/930/001-009
Empagliflozin Boehringer Ingelheim International GmbH
Jentadueto 2.5 mg/1000 mg film-coated tablets
EU/1/12/780/015-028
Metformin, Linagliptin Boehringer Ingelheim International GmbH
Jentadueto 2.5 mg/850 mg film-coated tablets
EU/1/12/780/001-014
Linagliptin, Metformin Boehringer Ingelheim International GmbH
Metalyse 10 000 units (50 mg) powder and solvent for solution for injection
EU/1/00/169/006
Tenecteplase Boehringer Ingelheim International GmbH
Metalyse 25mg Powder for solution for injection
EU/1/00/169/007
Tenecteplase Boehringer Ingelheim International GmbH
Metalyse 8 000 units (40 mg) powder and solvent for solution for injection
EU/1/00/169/005
Tenecteplase Boehringer Ingelheim International GmbH
Micardis 20 mg tablets
EU/1/98/090/009-012
Telmisartan Boehringer Ingelheim International GmbH
Micardis 40 mg tablets
EU/1/98/090/001-004
Telmisartan Boehringer Ingelheim International GmbH
Micardis 80 mg tablets
EU/1/98/090/005-008
Telmisartan Boehringer Ingelheim International GmbH
MicardisPlus 40 mg/12.5 mg tablets
EU/1/02/213/001-005
Telmisartan, Hydrochlorothiazide Boehringer Ingelheim International GmbH
MicardisPlus 80 mg/12.5 mg tablets
EU/1/02/213/006-010
Telmisartan, Hydrochlorothiazide Boehringer Ingelheim International GmbH
MicardisPlus 80 mg/25 mg tablets
EU/1/02/213/17-23
Telmisartan, Hydrochlorothiazide Boehringer Ingelheim International GmbH
MIRAPEXIN 0.088 mg tablets
EU/1/97/051/001-002
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.18 mg tablets
EU/1/97/051/003-004
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.26 mg prolonged-release tablets
EU/1/97/051/13-15
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.35 mg tablets
EU/1/97/051/011-012
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.52 mg prolonged-release tablets
EU/1/97/051/16-18
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 0.7 mg tablets
EU/1/97/051/005-006
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 1.05 mg prolonged-release tablets
EU/1/97/051/19-21
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 1.57 mg prolonged-release tablets
EU/1/97/051/028-30
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 2.1 mg prolonged-release tablets
EU/1/97/051/22-24
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 2.62 mg prolonged-release tablets
EU/1/97/051/031-33
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
MIRAPEXIN 3.15 mg prolonged-release tablets
EU/1/97/051/25-27
Pramipexole dihydrochloride monohydrate Boehringer Ingelheim International GmbH
Ofev 100 mg Soft capsule
EU/1/14/979/001-002
Nintedanib Boehringer Ingelheim International GmbH
Ofev 150 mg Soft capsule
EU/1/14/979/003-004
Nintedanib Boehringer Ingelheim International GmbH
Ofev 25mg Soft capsule
EU/1/14/979/009-012
Nintedanib esylate Boehringer Ingelheim International GmbH
Pradaxa 110 mg coated granules
EU/1/08/442/0029
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 110 mg hard capsules
EU/1/08/442/5-8
Dabigatran etexilate Boehringer Ingelheim International GmbH
Pradaxa 150 mg coated granules
EU/1/08/442/030
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 150 mg hard capsules
EU/1/08/442/009-013
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 20 mg coated granules
EU/1/08/442/025
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 30 mg coated granules
EU/1/08/442/0026
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 40 mg coated granules
EU/1/08/442/0027
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 50 mg coated granules
EU/1/08/442/028
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
1 2
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.